Polymorphism of OAS‐1 determines liver fibrosis progression in hepatitis C by reduced ability to inhibit viral replication
Open Access
- 3 September 2009
- journal article
- Published by Wiley in Liver International
- Vol. 29 (9) , 1413-1421
Abstract
Background: Progression of disease after hepatitis C virus (HCV) infection differs among individuals, indicating a possibility of participation of host genetic factors. 2′‐5′‐oligoadenylate synthetase 1 (OAS‐1), an important component of the innate immune system, has an antiviral function, and may therefore have a certain relationship with progression of disease.Aim: To evaluate single nucleotide polymorphisms (SNPs) of OAS‐1 and its relationship with the disease status of HCV infection.Methods: Six SNPs of OAS‐1 were selected and examined in 409 Japanese patients with chronic HCV infection using the TaqMan PCR genotyping method. The relationship of SNP genotypes and clinical manifestations of patients was analysed. Then, a pair of OAS‐1‐expression plasmids mimicking the clinical‐related SNPs were created and transfected into liver cells carrying the HCV subgenomic replicon or the full‐length genome, JFH1, and HCV replication after transfection was compared.Results: Patients with genotypes A/A, A/G and G/G of an SNP of OAS‐1 at the exon 3 of its coding sequence were at gradient increased risks of suffering from higher serum alanine aminotransferase (PP=0.001), higher degree of liver fibrosis (P=0.010) and higher presence of liver cirrhosis (P=0.001). By multivariate logistic regression analysis, genotype G/G was an independent factor associated with cirrhosis (P=0.013, odds ratio 3.11, 95% confidence interval 1.27–7.63). In liver cells, OAS‐1 with the G allele showed lower ability to inhibit virus replication than OAS‐1 with the A allele (P=0.004).Conclusions: The SNP of OAS‐1 at the exon 3 of its coding sequence was associated with progression of disease in Japanese patients with HCV infection.Keywords
This publication has 40 references indexed in Scilit:
- Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humansNature Genetics, 2005
- Synergistic Inhibition of Intracellular Hepatitis C Virus Replication by Combination of Ribavirin and Interferon‐αThe Journal of Infectious Diseases, 2004
- Association of TNF‐β polymorphism with disease severity among patients infected with hepatitis C virusJournal of Medical Virology, 2003
- Establishment of a method of anonymization of DNA samples in genetic researchJournal of Human Genetics, 2003
- Progression of fibrosis in chronic hepatitis CGastroenterology, 2003
- A nonsense mutation in the gene encoding 2′-5′-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory miceProceedings of the National Academy of Sciences, 2002
- Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver diseaseHepatology, 2002
- Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis CBlood, 2002
- Gene structure and function of the 2′-5′-oligoadenylate synthetase familyCellular and Molecular Life Sciences, 2000
- Natural history of liver fibrosis progression in patients with chronic hepatitis CThe Lancet, 1997